Completed PHASE2 INTERVENTIONAL 3-arm NCT01571804

Pregabalin Reduce the Sevoflurane Requirement

Does Pregabalin Reduce the Sevoflurane Requirement During Laparoscopic Cholecystectomy? Mansoura University Hospitals Experience.

Sponsor: Mansoura University

Conditions Elective Laparoscopic Cholecystectomy Sevoflurane Anesthesia

Interventions Placebo pregabalin

Updated 6 times since 2017 Last updated: May 4, 2012 Started: Dec 31, 2011 Primary completion: Feb 29, 2012 Completion: Mar 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01571804, this PHASE2 trial focuses on Elective Laparoscopic Cholecystectomy and Sevoflurane Anesthesia and remains completed. Sponsored by Mansoura University, it has been updated 6 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Dec 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mansoura University

Data source: Mansoura University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Al Mansurah, Egypt